|
US2809194A
(en)
*
|
|
1957-10-08 |
|
Thiadiazine type natriuretic agents |
|
US1286A
(en)
*
|
|
1839-08-13 |
|
Richard else |
|
US3108097A
(en)
*
|
|
1963-10-22 |
|
Ehnojs |
|
FR1103113A
(fr)
|
1954-04-15 |
1955-10-31 |
|
Triméthylol-alcanes et leur procédé de préparation
|
|
FR1217929A
(fr)
|
1958-03-03 |
1960-05-06 |
Ciba Geigy |
Procédé de préparation du 1,1-dioxyde de la 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine et de ses sels
|
|
BE578515A
(enExample)
*
|
1958-05-07 |
|
|
|
|
DE1302648B
(enExample)
|
1960-09-27 |
|
|
|
|
NL127065C
(enExample)
*
|
1964-04-22 |
|
|
|
|
NL137318C
(enExample)
*
|
1964-06-09 |
|
|
|
|
GB1415295A
(en)
|
1971-10-14 |
1975-11-26 |
Orchimed Sa |
Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof
|
|
US3716583A
(en)
*
|
1969-04-16 |
1973-02-13 |
Sumitomo Chemical Co |
Phenoxy carboxylic acid derivative
|
|
US3692895A
(en)
*
|
1970-09-08 |
1972-09-19 |
Norman A Nelson |
Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
|
|
DE2230383C3
(de)
*
|
1971-10-01 |
1981-12-03 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Phenoxyalkylcarbonsäurederivate und Verfahren zur Herstellung derselben
|
|
US4148923A
(en)
*
|
1972-05-31 |
1979-04-10 |
Synthelabo |
1-(3'-Trifluoromethylthiophenyl)-2-ethylaminopropane pharmaceutical composition and method for treating obesity
|
|
US3948973A
(en)
*
|
1972-08-29 |
1976-04-06 |
Sterling Drug Inc. |
Halocyclopropyl substituted phenoxyalkanoic acids
|
|
US4626549A
(en)
*
|
1974-01-10 |
1986-12-02 |
Eli Lilly And Company |
Treatment of obesity with aryloxyphenylpropylamines
|
|
JPS5195049A
(en)
*
|
1975-02-12 |
1976-08-20 |
|
* **********so*****no***tsu*****************************************ni*no
|
|
US4179515A
(en)
*
|
1975-02-12 |
1979-12-18 |
Orchimed S. A. |
Benzoylphenoxy propionic acid, esters thereof and pharmaceutical composition
|
|
US4235896A
(en)
*
|
1975-02-12 |
1980-11-25 |
Orchimed S.A. |
Benzyl-phenoxy acid esters and hyperlipaemia compositions containing the same
|
|
US4075000A
(en)
*
|
1975-05-27 |
1978-02-21 |
Eli Lilly And Company |
Herbicidal use of 4-amino-3,3-dimethyl-1-phenyl-2-azetidinones
|
|
US4472309A
(en)
*
|
1975-10-06 |
1984-09-18 |
Fujisawa Pharmaceutical Co., Ltd. |
2-Azetidinone compounds and processes for preparation thereof
|
|
US4304718A
(en)
*
|
1975-10-06 |
1981-12-08 |
Fujisawa Pharmaceutical Co., Ltd. |
2-Azetidinone compounds and processes for preparation thereof
|
|
US4576753A
(en)
*
|
1975-10-06 |
1986-03-18 |
Fujisawa Pharmaceutical Co., Ltd. |
Azetidinone compounds and processes for preparation thereof
|
|
US4166907A
(en)
*
|
1976-11-01 |
1979-09-04 |
E. R. Squibb & Sons, Inc. |
3,3-Dichloro-2-azetidinone derivatives having antiinflammatory activity
|
|
US4144232A
(en)
*
|
1976-12-23 |
1979-03-13 |
Eli Lilly And Company |
Substituted azetidin-2-one antibiotics
|
|
FR2403078A1
(fr)
*
|
1977-09-19 |
1979-04-13 |
Lafon Labor |
Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
|
|
IT1157365B
(it)
*
|
1977-10-24 |
1987-02-11 |
Sandoz Ag |
Medicamenti per trattare l'obesita' o ridurre il peso del corpo
|
|
FR2408577A1
(fr)
|
1977-11-14 |
1979-06-08 |
Devinter Sa |
Nouveau procede de synthese d'esters para chlorobenzoyl phenoxy isobutyriques
|
|
NZ191762A
(en)
|
1978-10-19 |
1982-09-14 |
Merck & Co Inc |
Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
|
|
US4250191A
(en)
*
|
1978-11-30 |
1981-02-10 |
Edwards K David |
Preventing renal failure
|
|
US4375475A
(en)
*
|
1979-08-17 |
1983-03-01 |
Merck & Co., Inc. |
Substituted pyranone inhibitors of cholesterol synthesis
|
|
US4260743A
(en)
*
|
1979-12-31 |
1981-04-07 |
Gist-Brocades N.V. |
Preparation of β-lactams and intermediates therefor
|
|
US4444784A
(en)
*
|
1980-08-05 |
1984-04-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
|
ES488665A0
(es)
|
1980-02-15 |
1980-12-16 |
Especialidades Farmaco Terape |
Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico
|
|
FR2494112B1
(enExample)
|
1980-11-19 |
1986-01-10 |
Laruelle Claude |
|
|
DE3107100A1
(de)
*
|
1981-02-20 |
1982-09-09 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Azaprostacycline, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
|
|
US4500456A
(en)
*
|
1981-03-09 |
1985-02-19 |
Eli Lilly And Company |
Preparation of 4-fluoroazetidinones using FClO3
|
|
US4784734A
(en)
*
|
1981-04-10 |
1988-11-15 |
Otsuka Kagaku Yakuhin Kabushiki Kaisha |
Azetidinone derivatives and process for the preparation of the same
|
|
US4602003A
(en)
*
|
1982-05-17 |
1986-07-22 |
Medical Research Foundation Of Oregon |
Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
|
|
US4602005A
(en)
*
|
1982-05-17 |
1986-07-22 |
Medical Research Foundation Of Oregon |
Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
|
|
US4443372A
(en)
*
|
1982-06-23 |
1984-04-17 |
Chevron Research Company |
1-Alkyl derivatives of 3-aryloxy-4-(2-carbalkoxy)-phenyl-azet-2-ones as plant growth regulators
|
|
US4534786A
(en)
*
|
1982-06-23 |
1985-08-13 |
Chevron Research Company |
1-Alkyl derivatives of 3-aryloxy-4-(2-carbalkoxy)-phenyl-azet-2-ones as plant growth regulators
|
|
US4595532A
(en)
*
|
1983-02-02 |
1986-06-17 |
University Of Notre Dame Du Lac |
N-(substituted-methyl)-azetidin-2-ones
|
|
CA1256650A
(en)
*
|
1983-03-25 |
1989-06-27 |
Toshinari Tamura |
Process of producing 2-azetidinone-4-substituted compounds, and medicaments containing the compounds
|
|
US4614614A
(en)
*
|
1983-03-28 |
1986-09-30 |
Ciba-Geigy Corporation |
Process for the manufacture of optically active azetidinones
|
|
US4675399A
(en)
*
|
1983-03-28 |
1987-06-23 |
Notre Dame University |
Cyclization process for β-lactams
|
|
WO1985004876A1
(fr)
*
|
1984-04-24 |
1985-11-07 |
Takeda Chemical Industries, Ltd. |
Derives de 2-azetidinone et leur procede de preparation
|
|
US4576749A
(en)
*
|
1983-10-03 |
1986-03-18 |
E. R. Squibb & Sons, Inc. |
3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
|
|
US4680391A
(en)
|
1983-12-01 |
1987-07-14 |
Merck & Co., Inc. |
Substituted azetidinones as anti-inflammatory and antidegenerative agents
|
|
US5229381A
(en)
*
|
1983-12-01 |
1993-07-20 |
Merck & Co., Inc. |
Substituted azetidinones as anti-inflammatory and antidegenerative agents
|
|
US5229510A
(en)
*
|
1983-12-01 |
1993-07-20 |
Merck & Co., Inc. |
β-lactams useful in determining the amount of elastase in a clinical sample
|
|
US4654362A
(en)
*
|
1983-12-05 |
1987-03-31 |
Janssen Pharmaceutica, N.V. |
Derivatives of 2,2'-iminobisethanol
|
|
FR2561916B1
(fr)
*
|
1984-03-30 |
1987-12-11 |
Lafon Labor |
Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
|
|
US4581170A
(en)
*
|
1984-08-03 |
1986-04-08 |
E. R. Squibb & Sons, Inc. |
N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
|
|
US4633017A
(en)
*
|
1984-08-03 |
1986-12-30 |
E. R. Squibb & Sons, Inc. |
N-hydroxy protecting groups and process for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
|
|
US4576748A
(en)
*
|
1984-09-17 |
1986-03-18 |
Merck & Co., Inc. |
3-Hydroxy-3-aminoethyl β-lactams
|
|
US4647576A
(en)
|
1984-09-24 |
1987-03-03 |
Warner-Lambert Company |
Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
|
|
US4620867A
(en)
*
|
1984-09-28 |
1986-11-04 |
Chevron Research Company |
1-carbalkoxyalkyl-3-aryloxy-4-(substituted-2'-carboxyphenyl)-azet-2-ones as plant growth regulators and herbicides
|
|
AR240698A1
(es)
*
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
|
US4642903A
(en)
*
|
1985-03-26 |
1987-02-17 |
R. P. Scherer Corporation |
Freeze-dried foam dosage form
|
|
US4680289A
(en)
*
|
1985-06-05 |
1987-07-14 |
Progenics, Inc. |
Treatment of obesity and diabetes using sapogenins
|
|
JPH0679559B2
(ja)
|
1985-06-06 |
1994-10-12 |
三共株式会社 |
光学活性アゼチジノン誘導体の製法
|
|
AU6849687A
(en)
|
1986-01-23 |
1987-08-14 |
Upjohn Company, The |
Antimicrobial n-acyl-2-azetidinones
|
|
EP0234484B1
(en)
*
|
1986-02-19 |
1993-10-20 |
Sanraku Incorporated |
Novel azetidinone derivatives
|
|
GB8607312D0
(en)
*
|
1986-03-25 |
1986-04-30 |
Ici Plc |
Therapeutic agents
|
|
AU7084587A
(en)
|
1986-04-01 |
1987-10-20 |
Upjohn Company, The |
Methylprednisolone/sodium carboxymethyl starch tablet composition
|
|
FR2598146B1
(fr)
*
|
1986-04-30 |
1989-01-20 |
Rech Ind |
Nouveau procede de preparation de fibrates.
|
|
DE3621861A1
(de)
*
|
1986-06-30 |
1988-01-14 |
Laszlo Dr Med Ilg |
Verwendung von aryloxycarbonsaeure-derivaten gegen dermatologische erkrankungen
|
|
JPS6317859A
(ja)
|
1986-07-11 |
1988-01-25 |
Sagami Chem Res Center |
フルオロアゼチジノン誘導体
|
|
FR2602423B1
(fr)
*
|
1986-08-08 |
1989-05-05 |
Ethypharm Sa |
Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
|
|
US4814354A
(en)
*
|
1986-09-26 |
1989-03-21 |
Warner-Lambert Company |
Lipid regulating agents
|
|
DE3780909T2
(de)
|
1986-10-03 |
1993-03-04 |
Lilly Co Eli |
7-((meta-substituiert)-phenylglycin)-1-carba-1-dethia-cephalosporine.
|
|
US4803266A
(en)
*
|
1986-10-17 |
1989-02-07 |
Taisho Pharmaceutical Co., Ltd. |
3-Oxoalkylidene-2-azetidinone derivatives
|
|
US5229362A
(en)
*
|
1986-12-15 |
1993-07-20 |
Eli Lilly And Company |
Antibiotic A10255 complex and factors, and process and production therefor
|
|
ZA879415B
(en)
|
1986-12-15 |
1989-08-30 |
Lilly Co Eli |
Antibiotic a10255 complex and factors,microorganisms,process and production therefor
|
|
IL84819A
(en)
|
1986-12-15 |
1993-07-08 |
Lilly Co Eli |
Antibiotic a10255 complex and factors, process, microorganisms, and production therefor
|
|
JPS63156788A
(ja)
*
|
1986-12-22 |
1988-06-29 |
Sanraku Inc |
光学活性アゼチジノン類
|
|
AU1422388A
(en)
|
1987-01-27 |
1988-08-10 |
Warner-Lambert Company |
Lipid regulating compositions
|
|
US5110730A
(en)
*
|
1987-03-31 |
1992-05-05 |
The Scripps Research Institute |
Human tissue factor related DNA segments
|
|
DE3877406T2
(de)
*
|
1987-04-28 |
1993-06-09 |
Fujisawa Astra Ltd |
Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
|
|
GB8710965D0
(en)
|
1987-05-08 |
1987-06-10 |
Smith Kline French Lab |
Pharmaceutical compositions
|
|
US5106833A
(en)
*
|
1987-07-23 |
1992-04-21 |
Washington University |
Coagulation inhibitors
|
|
ZA887409B
(en)
|
1987-10-06 |
1990-06-27 |
Lilly Co Eli |
Crystalline beta-lactam hydrate
|
|
US5091525A
(en)
*
|
1987-10-07 |
1992-02-25 |
Eli Lilly And Company |
Monohydrate and DMF solvates of a new carbacephem antibiotic
|
|
US4834846A
(en)
*
|
1987-12-07 |
1989-05-30 |
Merck & Co., Inc. |
Process for deblocking N-substituted β-lactams
|
|
US5385885A
(en)
|
1988-01-15 |
1995-01-31 |
Gasic; Gregory P. |
Inhibition of smooth muscle cell proliferation by antistasin and tick anticoagulant peptide
|
|
FR2627696B1
(fr)
*
|
1988-02-26 |
1991-09-13 |
Fournier Innovation Synergie |
Nouvelle forme galenique du fenofibrate
|
|
DE3807895A1
(de)
*
|
1988-03-10 |
1989-09-21 |
Knoll Ag |
Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
|
|
EP0333268A1
(en)
|
1988-03-18 |
1989-09-20 |
Merck & Co. Inc. |
Process for synthesis of a chiral 3-beta hydrogen (3R) 4-aroyloxy azetidinone
|
|
NZ228600A
(en)
|
1988-04-11 |
1992-02-25 |
Merck & Co Inc |
1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives
|
|
GB8813012D0
(en)
*
|
1988-06-02 |
1988-07-06 |
Norsk Hydro As |
Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals
|
|
FR2634376B1
(fr)
|
1988-07-21 |
1992-04-17 |
Farmalyoc |
Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
|
|
US4952689A
(en)
|
1988-10-20 |
1990-08-28 |
Taisho Pharmaceutical Co., Ltd. |
3-(substituted propylidene)-2-azetidinone derivates for blood platelet aggregation
|
|
CA2002596A1
(en)
|
1988-11-14 |
1990-05-14 |
Thomas M. Eckrich |
Hydrates of b-lactam antibiotic
|
|
CA1340977C
(en)
|
1988-11-15 |
2000-04-25 |
Monty Krieger |
Scavenger receptor protein and antibody thereto
|
|
US5073374A
(en)
*
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
US5112616A
(en)
*
|
1988-11-30 |
1992-05-12 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
US4876365A
(en)
*
|
1988-12-05 |
1989-10-24 |
Schering Corporation |
Intermediate compounds for preparing penems and carbapenems
|
|
US5260305A
(en)
|
1988-12-12 |
1993-11-09 |
E. R. Squibb & Sons, Inc. |
Combination of pravastatin and nicotinic acid or related acid and method for lowering serum cholesterol using such combination
|
|
FR2640621B1
(fr)
*
|
1988-12-19 |
1992-10-30 |
Centre Nat Rech Scient |
N-aryl-azetidinones, leur procede de preparation et leur utilisation comme inhibiteurs des elastases
|
|
US4990535A
(en)
*
|
1989-05-03 |
1991-02-05 |
Schering Corporation |
Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
|
|
CA2016467A1
(en)
|
1989-06-05 |
1990-12-05 |
Martin Eisman |
Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
|
|
JPH03108490A
(ja)
*
|
1989-06-30 |
1991-05-08 |
Shionogi & Co Ltd |
フォスフォリパーゼａ↓２阻害物質
|
|
US5021461A
(en)
*
|
1989-07-26 |
1991-06-04 |
Merrell Dow Pharmaceuticals Inc. |
Method of treating diabetes mellitus with bisphenol derivatives
|
|
US4983597A
(en)
|
1989-08-31 |
1991-01-08 |
Merck & Co., Inc. |
Beta-lactams as anticholesterolemic agents
|
|
IL95574A
(en)
|
1989-09-09 |
1994-11-11 |
Knoll Ag |
Colestyramine preparation
|
|
US5219574A
(en)
*
|
1989-09-15 |
1993-06-15 |
Cima Labs. Inc. |
Magnesium carbonate and oil tableting aid and flavoring additive
|
|
US5178878A
(en)
*
|
1989-10-02 |
1993-01-12 |
Cima Labs, Inc. |
Effervescent dosage form with microparticles
|
|
US5223264A
(en)
*
|
1989-10-02 |
1993-06-29 |
Cima Labs, Inc. |
Pediatric effervescent dosage form
|
|
US5188825A
(en)
*
|
1989-12-28 |
1993-02-23 |
Iles Martin C |
Freeze-dried dosage forms and methods for preparing the same
|
|
CA2039763A1
(en)
|
1990-04-30 |
1991-10-31 |
Henry Y. Pan |
Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination
|
|
US5298497A
(en)
|
1990-05-15 |
1994-03-29 |
E. R. Squibb & Sons, Inc. |
Method for preventing onset of hypertension employing a cholesterol lowering drug
|
|
CA2040865C
(en)
|
1990-05-15 |
2002-07-23 |
James L. Bergey |
Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
|
|
US5622985A
(en)
|
1990-06-11 |
1997-04-22 |
Bristol-Myers Squibb Company |
Method for preventing a second heart attack employing an HMG CoA reductase inhibitor
|
|
CA2042526A1
(en)
|
1990-06-11 |
1991-12-12 |
Adeoye Y. Olukotun |
Method for preventing a second heart attack employing an hmg coa reductase inhibitor
|
|
US5120729A
(en)
|
1990-06-20 |
1992-06-09 |
Merck & Co., Inc. |
Beta-lactams as antihypercholesterolemics
|
|
CA2046672A1
(en)
*
|
1990-07-17 |
1992-01-18 |
Raymond Frank Brown |
Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereof
|
|
CA2048395A1
(en)
|
1990-08-23 |
1992-02-24 |
Henry Y. Pan |
Method for preventing onset of or treating type iii hyperlipoproteinemia employing pravastatin
|
|
US5120713A
(en)
*
|
1990-09-10 |
1992-06-09 |
Applied Research Systems Ars Holding N.V. |
Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
|
|
US5075313A
(en)
|
1990-09-13 |
1991-12-24 |
Eli Lilly And Company |
3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof
|
|
IL99658A0
(en)
|
1990-10-15 |
1992-08-18 |
Merck & Co Inc |
Substituted azetidinones and pharmaceutical compositions containing them
|
|
US5130333A
(en)
*
|
1990-10-19 |
1992-07-14 |
E. R. Squibb & Sons, Inc. |
Method for treating type II diabetes employing a cholesterol lowering drug
|
|
US5190970A
(en)
*
|
1990-10-19 |
1993-03-02 |
E. R. Squibb & Sons, Inc. |
Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
|
|
CA2052014A1
(en)
|
1990-10-19 |
1992-04-20 |
Henry Y. Pan |
Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
|
|
JP2640986B2
(ja)
*
|
1990-11-08 |
1997-08-13 |
高砂香料工業株式会社 |
（１′ｒ，３ｓ）―３―（１′―ヒドロキシエチル）―アゼチジン―２―オン又はその誘導体の製造法
|
|
IL100091A
(en)
|
1990-12-12 |
1998-08-16 |
Zeneca Ltd |
Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
|
|
US5552160A
(en)
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
|
AU642066B2
(en)
|
1991-01-25 |
1993-10-07 |
Nanosystems L.L.C. |
X-ray contrast compositions useful in medical imaging
|
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US5145684A
(en)
*
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
IT1244699B
(it)
|
1991-02-01 |
1994-08-08 |
Luso Farmaco Inst |
Processo per la preparazione di acidi 3 acilammino-4- carbamoilossimetil-2-azetidinone-l-solfonici ed intermedi per la loro preparazione
|
|
US5157025A
(en)
*
|
1991-04-01 |
1992-10-20 |
E. R. Squibb & Sons, Inc. |
Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
|
|
US5348953A
(en)
|
1991-06-25 |
1994-09-20 |
Merck & Co., Inc. |
Substituted azetidinones as anti-inflammatory and antidegenerative agents
|
|
US5464632C1
(en)
|
1991-07-22 |
2001-02-20 |
Prographarm Lab |
Rapidly disintegratable multiparticular tablet
|
|
AU658441B2
(en)
|
1991-07-23 |
1995-04-13 |
Schering Corporation |
Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
|
|
US5688787A
(en)
*
|
1991-07-23 |
1997-11-18 |
Schering Corporation |
Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof
|
|
US5688785A
(en)
|
1991-07-23 |
1997-11-18 |
Schering Corporation |
Substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
US5561227A
(en)
|
1991-07-23 |
1996-10-01 |
Schering Corporation |
Process for the stereospecific synthesis of azetidinones
|
|
JP2620437B2
(ja)
|
1991-09-27 |
1997-06-11 |
宇部興産株式会社 |
ω−ヒドロキシ−（ω−３）−ケトニトリルおよびω−ヒドロキシ脂肪酸の製法
|
|
WO1993007167A1
(en)
|
1991-10-04 |
1993-04-15 |
The Procter & Gamble Company |
Cholesterol lowering compounds and process for making them
|
|
US5162117A
(en)
*
|
1991-11-22 |
1992-11-10 |
Schering Corporation |
Controlled release flutamide composition
|
|
CA2123684A1
(en)
|
1991-11-25 |
1993-06-10 |
Douglas J. M. Allen |
Method for making steroidal peracyl glycosides
|
|
DE4203932A1
(de)
|
1992-02-11 |
1993-08-12 |
Deutsche Aerospace |
Sende-/empfangsmodul
|
|
US6063764A
(en)
|
1992-06-01 |
2000-05-16 |
Washington University & Chiron Corp. |
Method for using lipoprotein associated coagulation inhibitor to treat sepsis
|
|
BR9306619A
(pt)
|
1992-06-26 |
1998-12-08 |
Pfizer |
Glicosídeos esteroidais para o tratamento da hipercolesterolemia
|
|
US5278176A
(en)
|
1992-08-21 |
1994-01-11 |
Abbott Laboratories |
Nicotine derivatives that enhance cognitive function
|
|
CA2147129A1
(en)
|
1992-10-27 |
1994-05-11 |
James B. Doherty |
New substituted azetidinones as anti-inflammatory and antidegenerative agents
|
|
US5631363A
(en)
|
1992-11-13 |
1997-05-20 |
Tanabe Seiyaku Co., Ltd. |
Azetidinone compound and process for preparation thereof
|
|
NZ248813A
(en)
|
1992-11-25 |
1995-06-27 |
Eastman Kodak Co |
Polymeric grinding media used in grinding pharmaceutical substances
|
|
WO1994020535A1
(en)
|
1992-12-11 |
1994-09-15 |
Corvas International, Inc. |
ECOTIN AS A FACTOR Xa, XIa, AND XIIa INHIBITOR
|
|
US5429824A
(en)
|
1992-12-15 |
1995-07-04 |
Eastman Kodak Company |
Use of tyloxapole as a nanoparticle stabilizer and dispersant
|
|
US5358852A
(en)
|
1992-12-21 |
1994-10-25 |
Eastman Kodak Company |
Use of calcium in immunoassay for measurement of C-reactive protein
|
|
LT3300B
(en)
*
|
1992-12-23 |
1995-06-26 |
Schering Corp |
Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
|
|
LT3595B
(en)
|
1993-01-21 |
1995-12-27 |
Schering Corp |
Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
|
|
US5563264A
(en)
|
1993-02-10 |
1996-10-08 |
Shionogi & Co., Ltd. |
Preparation of βlactam compounds
|
|
US5503846A
(en)
|
1993-03-17 |
1996-04-02 |
Cima Labs, Inc. |
Base coated acid particles and effervescent formulation incorporating same
|
|
US5412092A
(en)
|
1993-04-23 |
1995-05-02 |
Bristol-Myers Squibb Company |
N-substituted 2-azetidinones
|
|
IL109568A0
(en)
|
1993-05-19 |
1994-08-26 |
Fujisawa Pharmaceutical Co |
Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
|
|
US5703188A
(en)
|
1993-06-02 |
1997-12-30 |
Geltex Pharmaceuticals, Inc. |
Process for removing bile salts from a patient and compositions therefor
|
|
US5550229A
(en)
|
1993-06-23 |
1996-08-27 |
Tanabe Seiyaku Co., Ltd. |
Alkylation process for preparing azetidinone compound and starting compound therefor
|
|
PT707567E
(pt)
|
1993-07-09 |
2002-01-30 |
Schering Corp |
Processo de sintese de azetidinonas
|
|
ATE208615T1
(de)
|
1993-07-09 |
2001-11-15 |
Scherer Corp R P |
Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
|
|
AU7376494A
(en)
|
1993-08-04 |
1995-02-28 |
Andrulis Pharmaceuticals Corporation |
Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents
|
|
AU7397094A
(en)
|
1993-08-30 |
1995-03-22 |
Merck & Co., Inc. |
Prevention and treatment of alzheimer's disease
|
|
US5622719A
(en)
|
1993-09-10 |
1997-04-22 |
Fuisz Technologies Ltd. |
Process and apparatus for making rapidly dissolving dosage units and product therefrom
|
|
US5895664A
(en)
|
1993-09-10 |
1999-04-20 |
Fuisz Technologies Ltd. |
Process for forming quickly dispersing comestible unit and product therefrom
|
|
US5851553A
(en)
|
1993-09-10 |
1998-12-22 |
Fuisz Technologies, Ltd. |
Process and apparatus for making rapidly dissolving dosage units and product therefrom
|
|
US5631365A
(en)
|
1993-09-21 |
1997-05-20 |
Schering Corporation |
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
US5976570A
(en)
|
1993-12-21 |
1999-11-02 |
Applied Analytical Industries, Inc. |
Method for preparing low dose pharmaceutical products
|
|
CA2180148A1
(en)
|
1993-12-28 |
1995-07-06 |
Michael Paul Deninno |
Hypocholesterolemic agents
|
|
US6369103B1
(en)
|
1994-01-18 |
2002-04-09 |
Bristol-Myers Squibb Company |
Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
|
|
US5595761A
(en)
|
1994-01-27 |
1997-01-21 |
The Board Of Regents Of The University Of Oklahoma |
Particulate support matrix for making a rapidly dissolving tablet
|
|
US5576014A
(en)
|
1994-01-31 |
1996-11-19 |
Yamanouchi Pharmaceutical Co., Ltd |
Intrabuccally dissolving compressed moldings and production process thereof
|
|
GB9401892D0
(en)
|
1994-02-01 |
1994-03-30 |
Boots Co Plc |
Therapeutic agents
|
|
US5635210A
(en)
|
1994-02-03 |
1997-06-03 |
The Board Of Regents Of The University Of Oklahoma |
Method of making a rapidly dissolving tablet
|
|
US5627176A
(en)
*
|
1994-03-25 |
1997-05-06 |
Schering Corporation |
Substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
GB9406074D0
(en)
|
1994-03-26 |
1994-05-18 |
Glaxo Spa |
Chemical process
|
|
DE4414538A1
(de)
|
1994-04-26 |
1995-11-02 |
Klinge Co Chem Pharm Fab |
Präparate zur Therapie der kombinierten Hyperlipidämie mit einem Gehalt an einem p-Oxybenzoesäurederivat und einem Fibrat
|
|
US5554746A
(en)
|
1994-05-16 |
1996-09-10 |
Isis Pharmaceuticals, Inc. |
Lactam nucleic acids
|
|
US5718388A
(en)
|
1994-05-25 |
1998-02-17 |
Eastman Kodak |
Continuous method of grinding pharmaceutical substances
|
|
TW384224B
(en)
|
1994-05-25 |
2000-03-11 |
Nano Sys Llc |
Method of preparing submicron particles of a therapeutic or diagnostic agent
|
|
US5567439A
(en)
|
1994-06-14 |
1996-10-22 |
Fuisz Technologies Ltd. |
Delivery of controlled-release systems(s)
|
|
WO1995035277A1
(en)
*
|
1994-06-20 |
1995-12-28 |
Schering Corporation |
Substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
US6429289B1
(en)
|
1994-06-23 |
2002-08-06 |
Massachusetts Institute Of Technology |
Class BI and CI scavenger receptors
|
|
US5807834A
(en)
|
1994-09-20 |
1998-09-15 |
Pfizer Inc. |
Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor
|
|
GB9421836D0
(en)
|
1994-10-28 |
1994-12-14 |
Scherer Corp R P |
Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
|
|
GB9421816D0
(en)
|
1994-10-29 |
1994-12-14 |
Smithkline Beecham Plc |
Novel compounds
|
|
US5633246A
(en)
|
1994-11-18 |
1997-05-27 |
Schering Corporation |
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
US5624920A
(en)
|
1994-11-18 |
1997-04-29 |
Schering Corporation |
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
US5656624A
(en)
*
|
1994-12-21 |
1997-08-12 |
Schering Corporation |
4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
|
|
WO1996019451A1
(en)
|
1994-12-22 |
1996-06-27 |
Smithkline Beecham Plc |
Substituted azetidin-2-ones for treatment of atherosclerosis
|
|
US5902726A
(en)
|
1994-12-23 |
1999-05-11 |
Glaxo Wellcome Inc. |
Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
|
|
HU226208B1
(en)
|
1994-12-28 |
2008-06-30 |
Janssen Pharmaceutica Nv |
Use of nebivolol for producing anti-atherogenic pharmaceuticals
|
|
US5545628A
(en)
|
1995-01-10 |
1996-08-13 |
Galephar P.R. Inc. |
Pharmaceutical composition containing fenofibrate
|
|
FR2730231B1
(fr)
|
1995-02-02 |
1997-04-04 |
Fournier Sca Lab |
Association de fenofibrate et de vitamine e, utilisation en therapeutique
|
|
US5639475A
(en)
|
1995-02-03 |
1997-06-17 |
Eurand America, Incorporated |
Effervescent microcapsules
|
|
US5518738A
(en)
|
1995-02-09 |
1996-05-21 |
Nanosystem L.L.C. |
Nanoparticulate nsaid compositions
|
|
US5591456A
(en)
|
1995-02-10 |
1997-01-07 |
Nanosystems L.L.C. |
Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
US5747001A
(en)
|
1995-02-24 |
1998-05-05 |
Nanosystems, L.L.C. |
Aerosols containing beclomethazone nanoparticle dispersions
|
|
US5998441A
(en)
|
1995-02-28 |
1999-12-07 |
Eli Lilly And Company |
Benzothiophene compounds, intermediates, compositions, and methods
|
|
US5639739A
(en)
|
1995-03-24 |
1997-06-17 |
The Dupont Merck Pharmaceutical Company |
Imidazole containing aminoboronic acids
|
|
US5759865A
(en)
|
1995-05-03 |
1998-06-02 |
Eli Lilly And Company |
Combinatorial process for synthesizing azetidinone analogs
|
|
DE19518988A1
(de)
|
1995-05-29 |
1996-12-05 |
Basf Ag |
Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit
|
|
JP3144624B2
(ja)
|
1995-06-02 |
2001-03-12 |
杏林製薬株式会社 |
Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
|
|
US5612378A
(en)
|
1995-06-06 |
1997-03-18 |
3-Dimensional Pharmaceuticals, Inc. |
Bis-arylsulfonylaminobenzamide derivatives and the use thereof as factor Xa inhibitors
|
|
US5607697A
(en)
|
1995-06-07 |
1997-03-04 |
Cima Labs, Incorporated |
Taste masking microparticles for oral dosage forms
|
|
US5612353A
(en)
|
1995-06-07 |
1997-03-18 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
|
|
AU6039296A
(en)
|
1995-06-07 |
1996-12-30 |
G.D. Searle & Co. |
Method to treat cardiofibrosis with a combination therapy of an angiotensin ii antagonist and an epoxy-steroidal aldoste rone antagonist
|
|
NZ286920A
(en)
|
1995-07-03 |
1997-06-24 |
Sankyo Co |
Use of combination of hmg-coa reductase inhibitors and of insulin sensitizers for the prevention/treatment of arteriosclerosis or xanthoma
|
|
FR2737121B1
(fr)
|
1995-07-27 |
1997-10-03 |
Cl Pharma |
Nouvelles formulations galeniques du fenofibrate et leurs applications
|
|
US5698527A
(en)
|
1995-08-08 |
1997-12-16 |
Merck & Co., Inc. |
Steroidal glycosides as antihyperlipidemic agents
|
|
FR2738817B1
(fr)
|
1995-09-14 |
1997-10-17 |
Adir |
Nouveaux acides et esters 2,2-dimethyl-omega-phenoxy alcanoiques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5618707A
(en)
|
1996-01-04 |
1997-04-08 |
Schering Corporation |
Stereoselective microbial reduction of 5-fluorophenyl-5-oxo-pentanoic acid and a phenyloxazolidinone condensation product thereof
|
|
US5808056A
(en)
|
1995-10-31 |
1998-09-15 |
Merck & Co., Inc. |
Process for preparing substituted azetidinones
|
|
PT877750E
(pt)
|
1995-10-31 |
2002-09-30 |
Schering Corp |
2-azetidinonas substituidas por acucar uteis como agentes hipocolesterolemiantes
|
|
AU7472896A
(en)
|
1995-11-02 |
1997-05-22 |
Schering Corporation |
Process for preparing 1-(4-fluorophenyl)-3(r)-(3(s)-hydroxy-3-({phenyl or 4-fluorophenyl})-propyl)-4(s)-(4-hydroxyphenyl)-2-azetidinon
|
|
BR9611306A
(pt)
|
1995-11-14 |
1999-12-28 |
Knoll Pharmaceuticals Co |
Preparação farmacêutica e, composto farmacêutica estável.
|
|
US5925333A
(en)
|
1995-11-15 |
1999-07-20 |
Massachusetts Institute Of Technology |
Methods for modulation of lipid uptake
|
|
JPH09143156A
(ja)
|
1995-11-17 |
1997-06-03 |
Tanabe Seiyaku Co Ltd |
アセトキシアゼチジノン誘導体の製法及びその合成中間体
|
|
US5807577A
(en)
|
1995-11-22 |
1998-09-15 |
Lab Pharmaceutical Research International Inc. |
Fast-melt tablet and method of making same
|
|
US5807578A
(en)
|
1995-11-22 |
1998-09-15 |
Lab Pharmaceutical Research International Inc. |
Fast-melt tablet and method of making same
|
|
EP0865429A1
(en)
|
1995-12-08 |
1998-09-23 |
Smithkline Beecham Plc |
Azetidinone compounds for the treatment of atherosclerosis
|
|
US6080767A
(en)
|
1996-01-02 |
2000-06-27 |
Aventis Pharmaceuticals Products Inc. |
Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
|
|
GB9600464D0
(en)
|
1996-01-09 |
1996-03-13 |
Smithkline Beecham Plc |
Novel method
|
|
US5847008A
(en)
|
1996-02-02 |
1998-12-08 |
Merck & Co., Inc. |
Method of treating diabetes and related disease states
|
|
US5859051A
(en)
|
1996-02-02 |
1999-01-12 |
Merck & Co., Inc. |
Antidiabetic agents
|
|
AU1856997A
(en)
|
1996-02-02 |
1997-08-22 |
Merck & Co., Inc. |
Method for raising hdl cholesterol levels
|
|
GB9604242D0
(en)
|
1996-02-28 |
1996-05-01 |
Glaxo Wellcome Inc |
Chemical compounds
|
|
DE19608750A1
(de)
|
1996-03-06 |
1997-09-11 |
Durachemie Gmbh & Co Kg |
Verfahren zur Herstellung von Fenofibrat-Präparaten
|
|
IL117702A0
(en)
|
1996-03-28 |
1996-07-23 |
Tel Aviv Medical Center Resear |
Drug for hyperlipoproteinemia
|
|
GB9606805D0
(en)
|
1996-03-30 |
1996-06-05 |
Glaxo Wellcome Inc |
Medicaments
|
|
JP2000508659A
(ja)
*
|
1996-04-17 |
2000-07-11 |
メルク エンド カンパニー インコーポレーテッド |
心血管疾患関連の危険性を低減する組み合わせ療法
|
|
US5858409A
(en)
|
1996-04-17 |
1999-01-12 |
Fmc Corporation |
Hydrolyzed cellulose granulations for pharmaceuticals
|
|
CZ341098A3
(cs)
|
1996-04-26 |
1999-03-17 |
Smithkline Beecham Plc |
Azetidinonové deriváty pro ošetřování aterosklerózy
|
|
US5843984A
(en)
|
1996-05-09 |
1998-12-01 |
Eli Lilly And Company |
Sulfated benzothiophene derivatives, methods of use and formulations containing same
|
|
ID16956A
(id)
*
|
1996-05-24 |
1997-11-27 |
Schering Corp |
Komposisi antijamur dengan ketersediaan hayati yang tertingkatkan
|
|
US5886171A
(en)
|
1996-05-31 |
1999-03-23 |
Schering Corporation |
3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones
|
|
US5739321A
(en)
|
1996-05-31 |
1998-04-14 |
Schering Corporation |
3-hydroxy γ-lactone based enantionselective synthesis of azetidinones
|
|
US6245743B1
(en)
|
1996-06-05 |
2001-06-12 |
Cor Therapeutics, Inc. |
Inhibitors of factor Xa
|
|
GB9611947D0
(en)
|
1996-06-07 |
1996-08-07 |
Glaxo Group Ltd |
Medicaments
|
|
EP0852117A4
(en)
|
1996-06-12 |
1999-02-03 |
Kyowa Hakko Kogyo Kk |
IMPROVEMENT OF LIPID METABOLISM
|
|
US5965553A
(en)
|
1996-06-20 |
1999-10-12 |
Pfizer Inc. |
Squalene synthetase inhibitors
|
|
AU4228997A
(en)
|
1996-07-09 |
1998-02-02 |
Merck & Co., Inc. |
Method for treating homozygous familial hypercholesterolemia
|
|
US6139873A
(en)
|
1996-07-10 |
2000-10-31 |
Cedars-Sinai Medical Center |
Combined pharmaceutical estrogen-androgen-progestin
|
|
US5883109A
(en)
|
1996-07-24 |
1999-03-16 |
Bristol-Myers Squibb Company |
Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
|
|
US5952003A
(en)
|
1996-08-01 |
1999-09-14 |
Novartis Corporation |
Terazosin capsules
|
|
EP0930882A2
(en)
|
1996-08-02 |
1999-07-28 |
Institut Pasteur De Lille |
Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
|
|
US6057342A
(en)
|
1996-08-16 |
2000-05-02 |
Dupont Pharmaceutical Co. |
Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
|
|
US6235706B1
(en)
|
1996-09-18 |
2001-05-22 |
Merck & Co., Inc. |
Combination therapy for reducing the risks associated with cardiovascular disease
|
|
US6251852B1
(en)
|
1996-09-18 |
2001-06-26 |
Merck & Co., Inc. |
Combination therapy for reducing the risks associated with cardiovascular disease
|
|
US5972389A
(en)
|
1996-09-19 |
1999-10-26 |
Depomed, Inc. |
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
|
|
JP2001503738A
(ja)
|
1996-09-23 |
2001-03-21 |
シンファー ラボラトリーズ，インコーポレーティッド |
システイン・プロテイナーゼ調節剤として有用な３，４―ジ置換アゼチジン―２―オン誘導体
|
|
WO1998014179A1
(en)
|
1996-10-01 |
1998-04-09 |
Cima Labs Inc. |
Taste-masked microcapsule compositions and methods of manufacture
|
|
US6262047B1
(en)
|
1996-10-11 |
2001-07-17 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
|
US5756470A
(en)
|
1996-10-29 |
1998-05-26 |
Schering Corporation |
Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
|
|
SI0946185T2
(sl)
|
1996-11-27 |
2010-08-31 |
Aventis Pharma Inc |
Farmacevtski sestavek, ki obsega spojino z anti-Xa-aktivnostjo in antagonistično spojino za agregacijo ploščic
|
|
US6090839A
(en)
|
1996-12-23 |
2000-07-18 |
Merck & Co., Inc. |
Antidiabetic agents
|
|
FR2758459B1
(fr)
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
|
US6066653A
(en)
|
1997-01-17 |
2000-05-23 |
Bristol-Myers Squibb Co. |
Method of treating acid lipase deficiency diseases with an MTP inhibitor and cholesterol lowering drugs
|
|
CA2276467A1
(en)
|
1997-01-17 |
1998-07-23 |
Bristol-Myers Squibb Company |
Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs
|
|
FR2758461A1
(fr)
|
1997-01-17 |
1998-07-24 |
Pharma Pass |
Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
|
|
ES2345614T3
(es)
*
|
1997-02-28 |
2010-09-28 |
Sanofi Pasteur Biologics Co. |
Vacunas quimericas de flavivirus.
|
|
WO1998043081A1
(en)
|
1997-03-26 |
1998-10-01 |
Ligand Pharmaceuticals Incorporated |
Treatment of gastrointestinal disease with ppar modulators
|
|
FR2761266B1
(fr)
*
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
|
|
WO1998043630A1
(en)
|
1997-04-02 |
1998-10-08 |
Brigham And Women's Hospital, Inc. |
Means of ascertaining an individual's risk profile for atherosclerotic disease
|
|
US6024981A
(en)
|
1997-04-16 |
2000-02-15 |
Cima Labs Inc. |
Rapidly dissolving robust dosage form
|
|
DE19716120A1
(de)
|
1997-04-17 |
1998-10-22 |
Europ Lab Molekularbiolog |
Verwendung von cholesterinsenkenden Mitteln
|
|
AU735760B2
(en)
|
1997-04-24 |
2001-07-12 |
Merck Sharp & Dohme Limited |
Use of a NK-1 receptor antagonist and an SSRI for treating obesity
|
|
ES2125198B1
(es)
*
|
1997-05-13 |
1999-11-16 |
Vita Invest Sa |
Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.
|
|
EA200800375A1
(ru)
|
1997-05-14 |
2008-06-30 |
Атеродженикс, Инк. |
Соединения и способы ингибирования экспрессии vcam-1
|
|
US6423754B1
(en)
|
1997-06-18 |
2002-07-23 |
Geltex Pharmaceuticals, Inc. |
Method for treating hypercholesterolemia with polyallylamine polymers
|
|
AU8355998A
(en)
|
1997-07-24 |
1999-02-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Medicinal compositions with cholesterol-lowering effect
|
|
US20010006644A1
(en)
|
1997-07-31 |
2001-07-05 |
David J. Bova |
Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
|
|
EP1017390B1
(en)
|
1997-07-31 |
2007-04-18 |
Kos Life Sciences, Inc. |
Coated tablet comprising nicotinic acid or a compound metabolized to nicotinic acid in an extended release form, and a coating containing an hmg-coa reductase inhibitor in an immediate release form
|
|
US6117429A
(en)
|
1997-08-11 |
2000-09-12 |
Weider Nutrition International, Inc |
Compositions and treatments for reducing potential unwanted side effects associated with long-term administration of androgenic testosterone precursors
|
|
US5886191A
(en)
|
1997-08-18 |
1999-03-23 |
Dupont Pharmaceuticals Company |
Amidinoindoles, amidinoazoles, and analogs thereof
|
|
US5869098A
(en)
|
1997-08-20 |
1999-02-09 |
Fuisz Technologies Ltd. |
Fast-dissolving comestible units formed under high-speed/high-pressure conditions
|
|
AR016827A1
(es)
*
|
1997-08-22 |
2001-08-01 |
Smithkline Beecham Corp |
PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
|
|
US6180660B1
(en)
|
1997-08-26 |
2001-01-30 |
Merck & Co., Inc. |
Cholesterol-lowering therapy
|
|
WO1999009967A2
(en)
|
1997-08-26 |
1999-03-04 |
Merck & Co., Inc. |
Cholesterol-lowering therapy
|
|
US6143885A
(en)
|
1997-08-27 |
2000-11-07 |
Merck & Co., Inc. |
Preparation of beta-methyl carbapenem intermediates
|
|
GT199800126A
(es)
|
1997-08-29 |
2000-01-29 |
|
Terapia de combinacion.
|
|
WO1999012903A1
(en)
|
1997-09-09 |
1999-03-18 |
Du Pont Pharmaceuticals Company |
Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
|
|
AU8996698A
(en)
|
1997-09-10 |
1999-03-29 |
Ono Pharmaceutical Co. Ltd. |
Peroxisome proliferator-activated receptor controllers
|
|
GB2329334A
(en)
|
1997-09-18 |
1999-03-24 |
Reckitt & Colmann Prod Ltd |
Cholesterol-lowering agents
|
|
AU9002798A
(en)
|
1997-09-19 |
1999-04-12 |
Ono Pharmaceutical Co. Ltd. |
Fused or nonfused benzene compounds
|
|
CA2214895C
(en)
|
1997-09-19 |
1999-04-20 |
Bernard Charles Sherman |
Improved pharmaceutical composition comprising fenofibrate
|
|
JP2001517617A
(ja)
|
1997-09-24 |
2001-10-09 |
ノヴァ モレキュラー インク． |
神経変性疾患の治療を目的としてａｐｏｅレベルを増加させる方法
|
|
IE970731A1
(en)
|
1997-10-07 |
2000-10-04 |
Fuisz Internat Ltd |
Product and method for the treatment of hyperlipidemia
|
|
EP1021405B1
(en)
|
1997-10-07 |
2002-09-25 |
Boehringer Ingelheim (Canada) Ltd. |
Azetidinone derivatives for the treatment of hcmv infections
|
|
US6147109A
(en)
|
1997-10-14 |
2000-11-14 |
The General Hospital Corporation |
Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors
|
|
US6005102A
(en)
|
1997-10-15 |
1999-12-21 |
American Home Products Corporation |
Aryloxy-alkyl-dialkylamines
|
|
AU9696198A
(en)
|
1997-10-17 |
1999-05-10 |
Aventis Pharmaceuticals Products Inc. |
Therapeutic uses of quinoline derivatives
|
|
US20030153541A1
(en)
|
1997-10-31 |
2003-08-14 |
Robert Dudley |
Novel anticholesterol compositions and method for using same
|
|
KR20010031501A
(ko)
|
1997-10-31 |
2001-04-16 |
추후제출 |
5-알파 환원효소 활성을 조절하는 방법 및 조성물
|
|
US6027747A
(en)
|
1997-11-11 |
2000-02-22 |
Terracol; Didier |
Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
|
|
WO1999029300A1
(en)
|
1997-12-10 |
1999-06-17 |
Rtp Pharma Inc. |
Self-emulsifying fenofibrate formulations
|
|
US5985936A
(en)
|
1997-12-18 |
1999-11-16 |
Forbes Medi-Tech, Inc. |
Method of preventing and delaying onset of Alzheimer's disease and composition therefor
|
|
US6008237A
(en)
|
1997-12-19 |
1999-12-28 |
Merck & Co., Inc. |
Arylthiazolidinedione derivatives
|
|
WO1999038498A1
(en)
|
1998-01-28 |
1999-08-05 |
Warner-Lambert Company |
Method for treating alzheimer's disease
|
|
WO1999038850A1
(en)
|
1998-01-29 |
1999-08-05 |
Dr. Reddy's Research Foundation |
Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
AU759255B2
(en)
|
1998-01-29 |
2003-04-10 |
Amgen, Inc. |
PPAR-gamma modulators
|
|
US6133001A
(en)
|
1998-02-23 |
2000-10-17 |
Schering Corporation |
Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(R)-[3(S)-Hydroxy-3-(4-fluorophenyl)propyl)]-4(S)-(4 -hydroxyphenyl)-2-azetidinone
|
|
DE69941777D1
(de)
|
1998-03-10 |
2010-01-21 |
Ono Pharmaceutical Co |
Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
|
|
US6235311B1
(en)
|
1998-03-18 |
2001-05-22 |
Bristol-Myers Squibb Company |
Pharmaceutical composition containing a combination of a statin and aspirin and method
|
|
US6080778A
(en)
|
1998-03-23 |
2000-06-27 |
Children's Medical Center Corporation |
Methods for decreasing beta amyloid protein
|
|
US6180625B1
(en)
|
1998-03-24 |
2001-01-30 |
Novo Nordisk A/S |
Heterocyclic compounds regulating clotting
|
|
DE69920888T2
(de)
|
1998-03-27 |
2006-02-02 |
Bristol-Myers Squibb Pharma Co. |
Disubstituierte pyrazoline und triazoline als faktor xa inhibitoren
|
|
CN1208326C
(zh)
*
|
1998-04-23 |
2005-06-29 |
雷迪实验室有限公司 |
杂环化合物及其在医药方面的应用、其制备方法及含有它们的药物组合物
|
|
TR200100137T2
(tr)
|
1998-04-29 |
2001-05-21 |
Ortho-Mcneil Pharmaceutical, Inc. |
Obesitenin ve başka bozuklukların tedavisinde yararlı nöropeptit Y Y5 reseptörü için ligandlar olarak N-ikameli aminotetralinler.
|
|
JP2002507543A
(ja)
|
1998-05-27 |
2002-03-12 |
ドクター・レディーズ・リサーチ・ファウンデーション |
二環系化合物、その製造方法およびそれらを含有する薬学的組成物
|
|
US6262042B1
(en)
|
1998-05-29 |
2001-07-17 |
Research Triangle Institute |
17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
|
|
FR2779347A1
(fr)
|
1998-06-05 |
1999-12-10 |
Arlette Guerry |
Procede de micronisation de substances medicamenteuses
|
|
AU4699099A
(en)
|
1998-06-24 |
2000-01-10 |
Merck & Co., Inc. |
Compositions and methods for treating elevated blood cholesterol
|
|
JP2002518448A
(ja)
|
1998-06-24 |
2002-06-25 |
メルク エンド カムパニー インコーポレーテッド |
高血中コレステロールを治療する組成物および方法
|
|
US6099865A
(en)
|
1998-07-08 |
2000-08-08 |
Fmc Corporation |
Croscarmellose taste masking
|
|
FR2781222A1
(fr)
|
1998-07-17 |
2000-01-21 |
Lipha |
Composes cycliques utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procede de preparation
|
|
AU5027299A
(en)
|
1998-07-31 |
2000-02-28 |
Novo Nordisk A/S |
Use of glp-1 and analogues for preventing type ii diabetes
|
|
ATE315033T1
(de)
|
1998-08-07 |
2006-02-15 |
Chiron Corp |
Subtituierte isoxazole derivate als estrogen rezeptor modulatore
|
|
US6147090A
(en)
|
1998-09-17 |
2000-11-14 |
Pfizer Inc. |
4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
|
|
FR2783421B1
(fr)
|
1998-09-17 |
2000-11-24 |
Cll Pharma |
Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
|
|
CZ20011035A3
(cs)
|
1998-09-30 |
2001-10-17 |
Warner-Lambert Company |
Léčivo pro prevenci nebo oddálení revaskularizace pomocí katetru u pacientů postiľených chorobou koronární artérie
|
|
US5919672A
(en)
|
1998-10-02 |
1999-07-06 |
Schering Corporation |
Resolution of trans-2-(alkoxycarbonylethyl)-lactams useful in the synthesis of 1-(4-fluoro-phenyl)-3(R)- (S)-hydroxy-3-(4-fluorophenyl)-propyl!-4(S)-(4-hydroxyphenyl)-2-azetidinone
|
|
US6248781B1
(en)
|
1998-10-21 |
2001-06-19 |
Novo Nordisk A/S |
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
|
|
WO2000023425A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
WO2000023445A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
EP1123297A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
WO2000023416A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
AU6190199A
(en)
|
1998-10-21 |
2000-05-08 |
Dr. Reddy's Research Foundation |
New compounds, their preparation and use
|
|
CA2253769C
(en)
|
1998-11-10 |
2000-09-26 |
Bernard Charles Sherman |
Pharmaceutical compositions comprising fenofibrate
|
|
US6472421B1
(en)
|
1998-11-13 |
2002-10-29 |
Nymox Corporation |
Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor
|
|
AU1742200A
(en)
|
1998-11-25 |
2000-06-13 |
Eli Lilly And Company |
Prevention and treatment of amyloid-associated disorders
|
|
SA99191255B1
(ar)
|
1998-11-30 |
2006-11-25 |
جي دي سيرل اند كو |
مركبات سيليكوكسيب celecoxib
|
|
CA2353981C
(en)
|
1998-12-07 |
2005-04-26 |
Schering Corporation |
Process for the synthesis of azetidinones
|
|
US6207822B1
(en)
|
1998-12-07 |
2001-03-27 |
Schering Corporation |
Process for the synthesis of azetidinones
|
|
US6277584B1
(en)
|
1998-12-16 |
2001-08-21 |
Dade Behring Inc. |
Method for calibrating a chemical analyzer with improved accuracy at low signal levels
|
|
DE19858789A1
(de)
|
1998-12-18 |
2000-06-21 |
Bayer Ag |
Kombination von Cerivastatin und Fibraten
|
|
EP1140036A2
(en)
|
1998-12-18 |
2001-10-10 |
Abbott Laboratories |
Novel formulations comprising lipid-regulating agents
|
|
AU2157400A
(en)
|
1998-12-23 |
2000-07-31 |
G.D. Searle & Co. |
Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
|
|
US6458850B1
(en)
|
1998-12-23 |
2002-10-01 |
G.D. Searle, Llc |
Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
|
|
JP2002533415A
(ja)
|
1998-12-23 |
2002-10-08 |
ジー．ディー．サール エルエルシー |
心臓血管に適用するための回腸胆汁酸輸送阻害剤およびニコチン酸誘導体の組み合わせ
|
|
DK1140189T3
(da)
|
1998-12-23 |
2003-09-15 |
Searle Llc |
Kombinationer af ileal galdesyre-transportinhibitorer og fibrinsyrederivater til cardiovaskulære indikationer
|
|
DE69911058T2
(de)
*
|
1998-12-23 |
2004-06-03 |
G.D. Searle Llc, Chicago |
Kombinationen einem ibat inhibitor und einem mtp inhibitor für kardiovaskuläre indikationen
|
|
EA004877B1
(ru)
|
1998-12-23 |
2004-08-26 |
Джи.Ди.Сирл Ллс |
Сочетания ингибиторов транспорта желчных кислот в подвздошной кишке и агентов, секвестрирующих желчные кислоты, для сердечно-сосудистых показаний
|
|
AU2157500A
(en)
|
1998-12-23 |
2000-07-31 |
G.D. Searle Llc |
Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
|
|
BR9916486A
(pt)
|
1998-12-23 |
2002-02-05 |
Searle Llc |
Combinações de inibidores do transporte de ácidos biliares no ìleo e inibidores da proteìna de transferência do ester colesteril para indicações cardiovasculares
|
|
AU3103800A
(en)
|
1998-12-23 |
2000-07-31 |
G.D. Searle Llc |
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acidderivatives for cardiovascular indications
|
|
AR022204A1
(es)
|
1999-01-08 |
2002-09-04 |
Norgine Bv |
Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende.
|
|
US6180138B1
(en)
|
1999-01-29 |
2001-01-30 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
|
GB0000710D0
(en)
|
1999-02-06 |
2000-03-08 |
Zeneca Ltd |
Drug combination
|
|
AU2690600A
(en)
|
1999-02-24 |
2000-09-14 |
Fuji Chemical Industries, Ltd. |
2-mercaptocarboxylic acid derivatives
|
|
JP2002538202A
(ja)
|
1999-03-08 |
2002-11-12 |
メルク エンド カムパニー インコーポレーテッド |
ＨＭＧ−ＣｏＡレダクターゼ阻害剤のジヒドロキシオープンアシッド及びその塩
|
|
EP1036563A1
(en)
|
1999-03-08 |
2000-09-20 |
MERCK & CO. INC. |
Delayed-release oral formulation of dihydroxy open acid simvastatin and salts and esters thereof
|
|
CA2363590A1
(en)
|
1999-03-10 |
2000-09-14 |
G.D. Searle & Co. |
Method and composition for administering a cyclooxygenase-2 inhibitor
|
|
TR200202077T2
(tr)
|
1999-03-11 |
2002-11-21 |
Nuclear Receptor Research Limited |
Prar nükleer reseptörleri için yeni ligandlar
|
|
WO2000056403A1
(en)
|
1999-03-19 |
2000-09-28 |
The Brigham And Women's Hospital, Inc. |
UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
|
|
WO2000057859A1
(en)
|
1999-03-31 |
2000-10-05 |
Abbott Laboratories |
Novel formulations comprising lipid-regulating agents
|
|
JP2002540174A
(ja)
|
1999-03-31 |
2002-11-26 |
アボット・ラボラトリーズ |
脂質調節剤を含有する新規製剤
|
|
JP3679715B2
(ja)
|
1999-04-05 |
2005-08-03 |
シェーリング コーポレイション |
１−（４−フルオロフェニル）−３（ｒ）−［３（ｓ）−ヒドロキシ−３−（４−フルオロフェニル）プロピル）］−４（ｓ）−（４−ヒドロキシフェニル）−２−アゼチジノンの調製のための立体選択的微生物還元
|
|
AU4343500A
(en)
|
1999-04-16 |
2000-11-02 |
Schering Corporation |
Use of azetidinone compounds
|
|
AU4250200A
(en)
|
1999-04-19 |
2000-11-02 |
Coelacanth Corporation |
Ppar-(gamma) agonists as agents for the treatment of type ii diabetes
|
|
EP1171431A1
(en)
|
1999-04-20 |
2002-01-16 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
JP2002542246A
(ja)
|
1999-04-20 |
2002-12-10 |
ノボ ノルディスク アクティーゼルスカブ |
新規な化合物、それらの製造及び使用
|
|
HUP0200807A3
(en)
|
1999-04-20 |
2003-03-28 |
Novo Nordisk As |
Substituted propionic acid derivatives, process for their preparation, pharmaceutical compositions containing them and their use
|
|
AU3958200A
(en)
|
1999-04-20 |
2000-11-02 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
CA2270306C
(en)
|
1999-04-27 |
2000-09-26 |
Bernard Charles Sherman |
Pharmaceutical compositions comprising co-micronized fenofibrate
|
|
US6033656A
(en)
|
1999-05-04 |
2000-03-07 |
Sumitomo Chemical Company, Limited |
Method of preventing or alleviating mammalian obesity
|
|
WO2000069445A1
(en)
|
1999-05-13 |
2000-11-23 |
Geltex Pharmaceuticals, Inc. |
Combination therapy for treating hypercholesterolemia
|
|
HK1044897A1
(zh)
|
1999-05-14 |
2002-11-08 |
Esperion Luv Development Inc. |
心绞痛和/或不典型心绞痛的治疗方法及其相关药物组合物和药剂盒
|
|
JP2003500439A
(ja)
|
1999-05-28 |
2003-01-07 |
アボット・ラボラトリーズ |
脂質調節剤を含む新規調合物
|
|
US6465011B2
(en)
|
1999-05-29 |
2002-10-15 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
|
JP4618845B2
(ja)
|
1999-06-09 |
2011-01-26 |
杏林製薬株式会社 |
ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体
|
|
US6372251B2
(en)
|
1999-06-11 |
2002-04-16 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
|
GB9913782D0
(en)
|
1999-06-14 |
1999-08-11 |
Smithkline Beecham Plc |
Novel compounds
|
|
EP1194146B1
(en)
|
1999-06-18 |
2006-07-19 |
Merck & Co., Inc. |
Arylthiazolidinedione and aryloxazolidinedione derivatives
|
|
US6207699B1
(en)
|
1999-06-18 |
2001-03-27 |
Richard Brian Rothman |
Pharmaceutical combinations for treating obesity and food craving
|
|
US6380191B1
(en)
|
1999-06-18 |
2002-04-30 |
Merck & Co. Inc. |
Arylthiazolidinedione and aryloxazolidinedione derivatives
|
|
GB9914977D0
(en)
|
1999-06-25 |
1999-08-25 |
Glaxo Group Ltd |
Chemical compounds
|
|
WO2001000579A1
(en)
|
1999-06-30 |
2001-01-04 |
Tularik Inc. |
COMPOUNDS FOR THE MODULATION OF PPARη ACTIVITY
|
|
ATE399554T1
(de)
|
1999-08-03 |
2008-07-15 |
Lilly Icos Llc |
Pharmazeutische zusammensetzung enthaltend tadalafil
|
|
EP1078632A1
(en)
|
1999-08-16 |
2001-02-28 |
Sanofi-Synthelabo |
Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
|
|
GB9919413D0
(en)
|
1999-08-18 |
1999-10-20 |
Zeneca Ltd |
Chemical compounds
|
|
GB9919411D0
(en)
|
1999-08-18 |
1999-10-20 |
Zeneca Ltd |
Chemical compounds
|
|
US6730687B1
(en)
|
1999-08-23 |
2004-05-04 |
Kyorin Pharmaceutical Co., Ltd. |
Substituted benzylthiazolidine-2, 4-dione derivatives
|
|
CA2382573C
(en)
|
1999-08-23 |
2007-05-22 |
Kyorin Pharmaceutical Co., Ltd. |
Substituted benzylthiazolidine-2,4-dione derivatives
|
|
EP1207156B1
(en)
|
1999-08-23 |
2005-05-18 |
Kyorin Pharmaceutical Co., Ltd. |
Substituted benzylthiazolidine-2,4-dione derivatives
|
|
WO2001016120A1
(en)
|
1999-08-27 |
2001-03-08 |
Eli Lilly And Company |
Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
|
|
AU782386C
(en)
|
1999-08-31 |
2006-08-10 |
Brigham And Women's Hospital |
Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases
|
|
EP1210345B1
(en)
|
1999-09-08 |
2004-03-03 |
Glaxo Group Limited |
Oxazole ppar antagonists
|
|
CA2384089A1
(en)
|
1999-09-08 |
2001-03-15 |
Genentech, Inc. |
Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
|
|
US6174665B1
(en)
|
1999-09-10 |
2001-01-16 |
Biex, Inc. |
Hormone replacement therapy monitoring
|
|
AU778282B2
(en)
|
1999-09-17 |
2004-11-25 |
Kyorin Pharmaceutical Co. Ltd. |
O-anisamide derivatives
|
|
JP2003509478A
(ja)
|
1999-09-21 |
2003-03-11 |
エモリー・ユニバーシティ |
血小板関連障害を処置する方法および組成物
|
|
AU782230B2
(en)
|
1999-09-22 |
2005-07-14 |
Serono Genetics Institute S.A. |
Methods of screening for compounds that modulate the LSR-leptin interaction and their use in the prevention and treatment of obesity-related diseases
|
|
CA2383140C
(en)
|
1999-09-24 |
2007-12-04 |
Kyorin Pharmaceutical Co., Ltd. |
Ppar.alpha. and ppar.gamma. inhibitors
|
|
AU2833701A
(en)
|
1999-09-30 |
2001-05-10 |
Shell Internationale Research Maatschappij B.V. |
Adducts of glycidylesters of alpha, alpha-branched carboxylic acids and carboxylic acids and poly(ortho ester) as intermediate for their preparation
|
|
WO2001022962A1
(en)
|
1999-09-30 |
2001-04-05 |
Merck & Co., Inc. |
Anti-hypercholesterolemic drug combination
|
|
AU7995300A
(en)
|
1999-10-05 |
2001-05-10 |
Bethesda Pharmaceuticals, Inc. |
Dithiolane derivatives
|
|
CA2386750A1
(en)
|
1999-10-22 |
2001-05-03 |
Merck & Co. Inc. |
Pharmaceuticals for treating obesity
|
|
CA2389973A1
(en)
|
1999-11-04 |
2001-05-10 |
Andrx Corporation |
Method of treating amyloid beta precursor disorders
|
|
TWI271192B
(en)
|
1999-11-11 |
2007-01-21 |
Kyorin Pharmaceutical Co Ltd |
Solid formulation for oral administration
|
|
BR0015491A
(pt)
|
1999-11-12 |
2002-10-15 |
Oncolytics Biotech Inc |
Métodos para tratar um distúrbio proliferativo celular mediado por ras em um mamìfero, para tratar um neoplasma tendo uma via-ras ativada em um humano, para inibir metástase de um neoplasma tendo uma via-ras ativada em um mamìfero, e para tratar um neoplasma suspeito de ter uma via-ras ativada em um mamìfero, composição farmacêutica, kit, e, método para tratar uma população de células compreendendo um neoplasma suspeito de ter uma via-ras ativada in vitro
|
|
MXPA02005528A
(es)
|
1999-12-03 |
2002-09-02 |
Kyoto Pharma Ind |
Compuestos heterociclicos sus sales y uso medicinal.
|
|
WO2001041770A2
(en)
|
1999-12-08 |
2001-06-14 |
Pharmacia Corporation |
Nanoparticulate eplerenone compositions
|
|
AU2276801A
(en)
|
1999-12-20 |
2001-07-03 |
Schering Corporation |
Extended release oral dosage composition
|
|
US6248359B1
(en)
|
2000-01-05 |
2001-06-19 |
Laboratorios Phoenix U.S.A., Inc. |
Multi-tablet oxybutynin system for treating incontinence
|
|
AU2001233299A1
(en)
|
2000-02-04 |
2001-08-14 |
Esperion Therapeutics Inc. |
Methods for treating alzheimer's disease
|
|
JP2003523336A
(ja)
|
2000-02-18 |
2003-08-05 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病及び脂質障害のためのアリールオキシ酢酸
|
|
AU2001229775A1
(en)
|
2000-02-29 |
2001-09-12 |
Bristol-Myers Squibb Company |
Low dose entecavir formulation and use
|
|
CA2406077C
(en)
|
2000-04-10 |
2010-07-20 |
Nicholas J. Wald |
Formulation for the prevention of cardiovascular disease
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
US20020013334A1
(en)
|
2000-06-15 |
2002-01-31 |
Robl Jeffrey A. |
HMG-CoA reductase inhibitors and method
|
|
US6191117B1
(en)
|
2000-07-10 |
2001-02-20 |
Walter E. Kozachuk |
Methods of producing weight loss and treatment of obesity
|
|
CA2415742A1
(en)
|
2000-07-25 |
2002-01-31 |
Merck & Co., Inc. |
N-substituted indoles useful in the treatment of diabetes
|
|
US20020132855A1
(en)
*
|
2000-08-03 |
2002-09-19 |
Nelson Edward B. |
Use of acetaminophen to prevent and treat arteriosclerosis
|
|
DE10042447A1
(de)
*
|
2000-08-29 |
2002-03-28 |
Aventis Pharma Gmbh |
Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports
|
|
JP2004513090A
(ja)
*
|
2000-09-27 |
2004-04-30 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体
|
|
ATE279425T1
(de)
|
2000-12-20 |
2004-10-15 |
Schering Corp |
Zuckersubstituierte 2-azetidinone verwendbar als hypocholesterdenische arzneimittel
|
|
US6982251B2
(en)
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
|
CA2431995A1
(en)
*
|
2000-12-21 |
2002-06-27 |
Aventis Pharma Deutschland Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
|
IL156550A0
(en)
*
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
|
|
IL156552A0
(en)
*
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
|
NZ542090A
(en)
|
2001-01-26 |
2006-09-29 |
Schering Corp |
Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
|
|
TW200840563A
(en)
|
2001-01-26 |
2008-10-16 |
Schering Corp |
Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(S) and treatments for vascular indications
|
|
KR20070120617A
(ko)
|
2001-01-26 |
2007-12-24 |
쉐링 코포레이션 |
치환된 아제티딘온 화합물을 포함하는 약제학적 조성물
|
|
PT1363668E
(pt)
|
2001-01-26 |
2007-11-07 |
Schering Corp |
Combinaçoes de sequestrante(s) de ácidos biliares e inibidor(es) de absorção de esterol e tratamento de indicações vasculares
|
|
IL156445A0
(en)
|
2001-01-26 |
2004-01-04 |
Schering Corp |
Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
|
|
EP1385548B1
(en)
|
2001-01-26 |
2007-05-23 |
Schering Corporation |
Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
|
|
EP1366012A4
(en)
*
|
2001-02-09 |
2005-11-02 |
Merck & Co Inc |
2-ARYLOXY-2-ARYLALKANIC ACIDS AGAINST DIABETES AND FAILURE CHANGES
|
|
DE10106787A1
(de)
|
2001-02-12 |
2002-08-22 |
Nanogate Gmbh |
Wasserfrei hydrolisierte Sol-Gel-Systeme
|
|
MXPA03007284A
(es)
|
2001-02-15 |
2003-12-04 |
Pfizer Prod Inc |
Agonistas de receptor activador del proliferador de peroxisomas.
|
|
EP1372632A1
(en)
|
2001-02-15 |
2004-01-02 |
Pfizer Products Inc. |
Proliferative activator receptor (ppar) compounds
|
|
AU2002336267B2
(en)
*
|
2001-03-08 |
2006-10-05 |
Merck & Co., Inc. |
Antihypertensive agent and cholesterol absorption inhibitor combination therapy
|
|
US7348334B2
(en)
*
|
2001-04-09 |
2008-03-25 |
Dr. Reddy's Laboratories Limited |
Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
|
WO2002081454A1
(en)
*
|
2001-04-09 |
2002-10-17 |
Dr. Reddy's Laboratories Ltd. |
Derivatives of aryl acids, their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
WO2002096415A2
(en)
|
2001-05-25 |
2002-12-05 |
Schering Corporation |
Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
|
|
JP2005505538A
(ja)
|
2001-08-22 |
2005-02-24 |
アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
アリール置換プロパノールアミン誘導体と他の活性成分との組み合わせ物およびその使用
|
|
WO2003018024A1
(de)
|
2001-08-22 |
2003-03-06 |
Aventis Pharma Deutschland Gmbh |
Kombinationspräparate von 1,4- benzothiepin-1,1-dioxidderivaten mit weiteren wirkstoffen und deren verwendung
|
|
US7056906B2
(en)
|
2001-09-21 |
2006-06-06 |
Schering Corporation |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
|
|
US20030119808A1
(en)
|
2001-09-21 |
2003-06-26 |
Schering Corporation |
Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
|
|
US7053080B2
(en)
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
|
EP1429756B1
(en)
|
2001-09-21 |
2006-11-22 |
Schering Corporation |
Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
|
|
DE60229406D1
(de)
|
2001-09-21 |
2008-11-27 |
Schering Corp |
Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
|
|
WO2003039542A1
(en)
|
2001-10-17 |
2003-05-15 |
Merck & Co. Inc. |
Combination therapy for treating alzheimer's disease
|
|
WO2003074101A1
(en)
|
2002-02-28 |
2003-09-12 |
Eli Lilly And Company |
Method of treating atherosclerosis and hypercholesterolemia
|
|
WO2003088962A1
(en)
|
2002-04-16 |
2003-10-30 |
Merck & Co., Inc. |
Combination therapy using a ppar alpha/gamma agonist
|